John Maraganore
North America, Massachusetts, United States, Boston
Description
Chief Executive Officer & Director at Alnylam Pharmaceuticals.
Investor Profile
John Maraganore has backed more than 5 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series Unknown, Series A rounds (top funding stages).
- Majority of deals are located in United States, The Netherlands.
- Strong thematic focus on Biotechnology, Medical, Biopharma.
Stage Focus
- Seed (60%)
- Series Unknown (20%)
- Series A (20%)
Country Focus
- United States (60%)
- The Netherlands (20%)
Industry Focus
- Biotechnology
- Medical
- Biopharma
- Health Care
- Therapeutics
- Artificial Intelligence (Ai)
- Life Science
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
